Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.
2.

Enhanced levels of soluble and membrane-bound CD137 levels in patients with acute coronary syndromes.

Dongming L, Zuxun L, Liangjie X, Biao W, Ping Y.

Clin Chim Acta. 2010 Mar;411(5-6):406-10. doi: 10.1016/j.cca.2009.12.011. Epub 2009 Dec 22.

PMID:
20026323
3.

Positive correlation between CD137 expression and complex stenosis morphology in patients with acute coronary syndromes.

Yan J, Gong J, Liu P, Wang C, Chen G.

Clin Chim Acta. 2011 May 12;412(11-12):993-8. doi: 10.1016/j.cca.2011.02.038. Epub 2011 Mar 8.

PMID:
21396356
4.

The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes.

Yan JC, Zhu J, Gao L, Wu ZG, Kong XT, Zong RQ, Zhan LZ.

Clin Chim Acta. 2004 May;343(1-2):155-9.

PMID:
15115688
5.
6.

Admission levels of soluble CD137 are increased in patients with acute pancreatitis and are associated with subsequent complications.

Shao Z, Schäffler A, Hamer O, Dickopf J, Goetz A, Landfried K, Voelk M, Kopp A, Herfarth H, Karrasch T, Brünnler T, Koh LK, Buechler C, Schwarz H.

Exp Mol Pathol. 2012 Feb;92(1):1-6. doi: 10.1016/j.yexmp.2011.09.012. Epub 2011 Sep 22.

PMID:
21963611
7.

Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.

Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T.

Am Heart J. 2013 May;165(5):716-24. doi: 10.1016/j.ahj.2013.02.008. Epub 2013 Mar 26.

PMID:
23622908
8.

Soluble CD40 ligand in acute coronary syndromes.

Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML; CAPTURE Study Investigators..

N Engl J Med. 2003 Mar 20;348(12):1104-11.

9.

Platelet collagen receptor glycoprotein VI as a possible novel indicator for the acute coronary syndrome.

Bigalke B, Geisler T, Stellos K, Langer H, Daub K, Kremmer E, Seizer P, May AE, Lindemann S, Gawaz M.

Am Heart J. 2008 Jul;156(1):193-200. doi: 10.1016/j.ahj.2008.02.010. Epub 2008 Apr 23.

PMID:
18585516
10.

The role of cardiac troponin T and other new biochemical markers in evaluation and risk stratification of patients with acute chest pain syndromes.

Solymoss BC, Bourassa MG, Wesolowska E, Dryda I, Théroux P, Mondor L, Perrault D, Gilfix BM.

Clin Cardiol. 1997 Nov;20(11):934-42.

11.

N-terminal pro B-type natriuretic peptide identifies patients with chest pain at high long-term cardiovascular risk.

van der Zee PM, Cornel JH, Bholasingh R, Fischer JC, van Straalen JP, De Winter RJ.

Am J Med. 2011 Oct;124(10):961-9. doi: 10.1016/j.amjmed.2011.05.026.

PMID:
21962317
12.

Prognostic significance of preprocedural troponin-I in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention.

Napan S, Kashinath RC, Kadri S, Orig MN, Khadra S.

Coron Artery Dis. 2010 Aug;21(5):261-5. doi: 10.1097/MCA.0b013e32833aa6fa.

PMID:
20555264
13.

Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome.

Cavusoglu E, Marmur JD, Hojjati MR, Chopra V, Butala M, Subnani R, Huda MS, Yanamadala S, Ruwende C, Eng C, Pinsky DJ.

Am J Med. 2011 Aug;124(8):724-30. doi: 10.1016/j.amjmed.2011.02.040.

PMID:
21787901
14.

Clinical significance of troponin elevations in acute decompensated diabetes without clinical acute coronary syndrome.

Eubanks A, Raza F, Alkhouli M, Glenn AN, Homko C, Kashem A, Bove A.

Cardiovasc Diabetol. 2012 Dec 27;11:154. doi: 10.1186/1475-2840-11-154.

15.

Predictive value of cardiac troponin T and I in hemodialysis patients.

Kalaji FR, Albitar S.

Saudi J Kidney Dis Transpl. 2012 Sep;23(5):939-45. doi: 10.4103/1319-2442.100868.

16.

Prognostic value of high-sensitivity troponin I versus troponin T in acute coronary syndromes.

Correia LC, Sodré FL, Lima JC, Sabino M, Brito M, Garcia G, Maraux M, Sousa AC, Noya-Rabelo M, Esteves JP.

Arq Bras Cardiol. 2012 May;98(5):406-12. Epub 2012 Apr 5. English, Portuguese.

17.

Long-term prognostic value of cardiac troponin I and T versus creatine kinase-MB mass after cardiac surgery in low-risk patients with stable symptoms.

Vikenes K, Andersen KS, Melberg T, Farstad M, Nordrehaug JE.

Am J Cardiol. 2010 Sep 15;106(6):780-6. doi: 10.1016/j.amjcard.2010.04.038. Epub 2010 Aug 1.

PMID:
20816117
18.

Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.

Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.

Indian Heart J. 2008 Nov-Dec;60(6):536-42.

PMID:
19276492
19.

Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.

LeLeiko RM, Vaccari CS, Sola S, Merchant N, Nagamia SH, Thoenes M, Khan BV.

Am J Cardiol. 2009 Sep 1;104(5):638-43. doi: 10.1016/j.amjcard.2009.04.047. Epub 2009 Jun 24.

PMID:
19699337
20.

Development of an optimized multimarker strategy for early risk assessment of patients with acute coronary syndromes.

Möckel M, Danne O, Müller R, Vollert JO, Müller C, Lueders C, Störk T, Frei U, Koenig W, Dietz R, Jaffe AS.

Clin Chim Acta. 2008 Jul 17;393(2):103-9. doi: 10.1016/j.cca.2008.03.022. Epub 2008 Mar 27.

PMID:
18423399

Supplemental Content

Support Center